𝔖 Bobbio Scriptorium

✦ LIBER ✦

PG18 A COST-EFFECTIVENESS EVALUATION—RETREATMENT WITH PEGYLATED INTERFERON ALFA 2B PLUS RIBAVIRIN IN HEPATITIS C PATIENTSWHO HAVE PREVIOUSLY RECEIVED INTERFERON-BASED THERAPY AND FAILED TO ATTAIN A SUSTAINED VIROLOGICAL RESPONSE

✍ Scribed by CJ Gibbons; J Morris; AK O'Sullivan

Book ID: 119597572
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 78 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66722-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PEG-interfeoon α-2b + ribavirin for trea

PEG-interfeoon α-2b + ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b + ribavirin therapy

✍ Sulkowski, Mark; Rothstein, Ken; Stein, Lawrence; Godofsky, Elliot; Goodman, Rus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

PEG-interferon α-2b plus ribavirin for t

PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon α or interferon α-2b plus ribavirin therapy: Mark Sulkowski, Johns Hopkins Medical Institutions, Baltimore, MD; Kenneth D Rothstein, Albert Einstein Medical Ctr, Philadelphia, PA; Lawrence Stein, Florham Park, New Jersey, Florham Park, NJ; Eliot Godofsky, Bradenton, Florida, Bradenton, FL; David Shoultz, PPD Development and University of Washington, Seattle, WA; Russ Hudnall, Mary Huff, Hepatitis Resource Network, Tacoma, WA; Douglas Dieterich, New York University School of Medicine, New York, NY

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB